Fig. 3 | Scientific Reports

Fig. 3

From: Fecal microbiome predicts treatment response after the initiation of semaglutide or empagliflozin uptake

Fig. 3

Changes in the CLR-transformed abundances of bacterial genera in the semaglutide and empagliflozin study group. (a) Semaglutide study group (GLP-1-RA). (b) Empagliflozin study group (SGLT-2i). Genera detected as nominally significant in the repeated measures ANOVA analysis are shown. The p-values on the plot refer to post-hoc analysis using pairwise t-tests to compare the changes between the baseline timepoint and later timepoints. BL—baseline, M1—1st month of treatment, M3—3rd month, M12—12th month.

Back to article page